The sensitivity, specificity, positive predictive value and negative predictive value when using the different cut-offs of plasma M30 and serum ALT, AST and GGT levels for prediction of NAFLD and NASH are shown in Tables 2 and 3. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.